Comprehensive mutational profiling in advanced systemic mastocytosis-Reference-Cited by-同舟云学术

Comprehensive mutational profiling in advanced systemic mastocytosis

Published:2013-10-03 Issue:14 Volume:122 Page:2460-2466
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Schwaab Juliana¹,Schnittger Susanne²,Sotlar Karl³,Walz Christoph³,Fabarius Alice¹,Pfirrmann Markus⁴,Kohlmann Alexander²,Grossmann Vera²,Meggendorfer Manja²,Horny Hans-Peter³,Valent Peter⁵,Jawhar Mohamad¹,Teichmann Martina¹,Metzgeroth Georgia¹,Erben Philipp¹,Ernst Thomas⁶,Hochhaus Andreas⁶,Haferlach Torsten²,Hofmann Wolf-Karsten¹,Cross Nicholas C. P.⁷⁸,Reiter Andreas¹

Affiliation:

1. III. Medizinische Klinik, Hämatologie und Onkologie, Universitätsmedizin Mannheim, Mannheim, Germany;

2. Munich Leukemia Laboratory, Munich, Germany;

3. Pathologisches Institut Munich, and

4. Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, Munich, Germany;

5. Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria;

6. Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany;

7. Wessex Regional Genetics Laboratory, Salisbury, United Kingdom; and

8. Faculty of Medicine, University of Southampton, Southampton, United Kingdom

Abstract

Key Points Additional genetic aberrations apart from KIT D816V are found in advanced systemic mastocytosis. Additional genetic aberrations apart from KIT D816V are associated with a significant reduction of overall survival.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/14/2460/1370319/2460.pdf

Reference41 articles.

1. Diagnostic criteria and classification of mastocytosis: a consensus proposal.;Valent;Leuk Res,2001

2. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.;Pardanani;Am J Hematol,2012

3. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.;Valent;Eur J Clin Invest,2007

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutation;Leukemia Research Reports;2024

2. Recent Advances in the Therapeutic Management of Advanced Systemic Mastocytosis;Diagnostics;2023-12-29

3. Mastocytosis—a frequently unrecognized disease;Die Dermatologie;2023-12-12

4. Mastocytosis demystified;Hematology;2023-12-08

5. Review and Updates on Systemic Mastocytosis and Related Entities;Cancers;2023-11-28